Portal Hypertension Completed Phase 2 Trials for Belapectin (DB15125)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02462967Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash CirrhosisTreatment